Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis
- 1 January 1998
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 47 (1-3) , 71-79
- https://doi.org/10.1016/s0165-0327(97)00120-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Serotonin Reuptake Inhibitor WithdrawalJournal of Clinical Psychopharmacology, 1996
- O-19-6: A six month sertraline fluoxetine comparative study in depressed outpatients: Outcome and costsEuropean Neuropsychopharmacology, 1996
- Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressantsPublished by American Medical Association (AMA) ,1996
- A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary careJournal of Affective Disorders, 1996
- Selective Serotonin Reuptake InhibitorsPharmacoEconomics, 1996
- Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance OrganizationJournal of International Medical Research, 1995
- Assessing the Case for Social ExperimentsJournal of Economic Perspectives, 1995
- Cost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugsJournal of Clinical Epidemiology, 1995
- Comparing Public and Private Schools: The Puzzling Role of Selectivity BiasJournal of Business & Economic Statistics, 1985
- Generalized Econometric Models with SelectivityEconometrica, 1983